GER Equity Snapshot

NP5 Weekly Equity Report

Newron Pharmaceuticals S.p.A.

Interactive chart JSON snapshot
Latest Close 13.15 EUR 12 Jun 2026
1W Return -1.5% latest completed week
4W Return -17.8% short-term follow-through
12W Return -17.7% quarterly tape
Trend Breadth 51.9% 27 of 52 weeks active
Volume Ratio 0.5x vs 13-week average
Company Brief

What the company does

Newron Pharmaceuticals S.p.A., a biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson's in the European Union, the United Kingdom, the United States, Latin America, Switzerland, and Japan. The company's lead compound includes Evenamide, an add-on therapy for the treatment of Schizophrenia and treatment-resistant schizophrenia, which is in Phase III clinical trial; and Ralfinamide for the treatment of rare neuropathic pain indication. It has a strategic partnership with …

Snapshot

What the weekly tape is saying

NP5 closed the latest completed week at 13.15 EUR. The 4-week return is -17.8% and the 12-week return is -17.7%. Trend Signal is inactive, Market Dynamics is -1.17. Setup signature: Risk-first tape with a 13/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -32.4%
Volume 0.5x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 29 Persistence of active Trend Signal over the last year and current streak.
Momentum 0 Blend of 4-week and 12-week follow-through.
Dynamics 29 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 0 Relative leadership and short-term RS change.
Volume 22 Participation compared with the 13-week volume baseline.
Risk Control 0 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
19.46 EUR
Vs Trend Line
-32.4%
Fair Value
10.49 EUR
Vs Fair Value
25.4%
52W High
34.65 EUR
52W Low
7.06 EUR
Drawdown
-62.0%
Range Position
22.1%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -1.5%
4W -17.8%
12W -17.7%
26W -39.3%
52W 66.2%

Trend read

Active Streak
0 weeks
52W Active Weeks
27
52W Active Breadth
51.9%
Sector Scope
DE Healthcare
Sector Rank
41 of 80
Sector Percentile
49.4%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-1.17
4W MD Change
6.7%
Relative Strength
-17.93
4W RS Change
-415.8%
Expectation
Undecided
Probability
46.89%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
16.4K
13W Average
31.3K
52W Average
29.5K
Vs 13W
0.5x
Vs 52W
0.6x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
6.8%
52W Volatility
9.1%
Upside Weeks
27
Downside Weeks
25
Downside Breadth
48.1%
Avg Gain / Loss
8.1% / -5.9%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
GER
Country
DE
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Market Cap
315.2M

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 13.15 EUR -1.5% 19.46 EUR 10.49 EUR -1.17 -17.93 16.4K Off
5 Jun 2026 13.35 EUR -11.9% 19.56 EUR 10.43 EUR -1.16 -16.62 20.7K Off
29 May 2026 15.15 EUR -1.3% 19.63 EUR 10.38 EUR -1.21 -6.10 23.9K Off
22 May 2026 15.35 EUR -4.1% 19.66 EUR 10.31 EUR -1.28 -3.25 21.4K Off
15 May 2026 16.00 EUR 8.1% 19.66 EUR 10.24 EUR -1.26 5.68 23.0K Off
8 May 2026 14.80 EUR -6.6% 19.60 EUR 10.16 EUR -1.25 -2.89 21.4K Off
1 May 2026 15.85 EUR -8.1% 19.66 EUR 10.10 EUR -1.20 4.98 26.9K Off
24 Apr 2026 17.25 EUR -4.2% 19.59 EUR 10.03 EUR -1.17 16.07 32.1K Off
17 Apr 2026 18.00 EUR 8.8% 19.39 EUR 9.94 EUR -1.07 19.72 37.5K Off
10 Apr 2026 16.55 EUR -0.3% 19.16 EUR 9.86 EUR -1.10 15.68 16.8K Off
3 Apr 2026 16.60 EUR 3.6% 18.93 EUR 9.78 EUR -1.06 20.59 27.7K Off
27 Mar 2026 16.02 EUR 0.3% 18.70 EUR 9.71 EUR -1.03 22.44 111.7K Off
20 Mar 2026 15.98 EUR -15.5% 18.47 EUR 9.65 EUR -1.06 23.08 28.0K On
13 Mar 2026 18.92 EUR -4.5% 18.21 EUR 9.58 EUR -0.96 40.65 23.3K On